Vident Advisory’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$436K	Sell	18,241 -2,078	-10%	-$49.7K	﹤0.01%	1142
2025 Q1	$505K	Sell	20,319 -9,035	-31%	-$225K	0.01%	1027
2024 Q4	$553K	Sell	29,354 -1,493	-5%	-$28.1K	0.01%	889
2024 Q3	$464K	Buy	+30,847	New	+$464K	0.01%	963